Immunogenicity of Biopharmaceuticals is the first book to comprehensively address the potential of an immune response to biopharmaceuticals. It is intended to give a broad overview of the current state-of-the-art regarding this subject. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
Immunogenicity of Biopharmaceuticals is the first book to comprehensively address the potential of an immune response to biopharmaceuticals. It is intended to give a broad overview of the current state-of-the-art regarding this subject. The chapters range from an overview of the immune system and factors that may trigger the immune system, via detection of antibodies and clinical implications, to various case examples and the regulatory view on immunogenicity.
Imprint | Springer-Verlag New York |
Country of origin | United States |
Series | Biotechnology: Pharmaceutical Aspects, VIII |
Release date | November 2010 |
Availability | Expected to ship within 10 - 15 working days |
First published | 2008 |
Editors | Marco Weert, Eva Horn Moller |
Dimensions | 254 x 178 x 14mm (L x W x T) |
Format | Paperback |
Pages | 266 |
Edition | Softcover reprint of hardcover 1st ed. 2008 |
ISBN-13 | 978-1-4419-2608-1 |
Barcode | 9781441926081 |
Categories | |
LSN | 1-4419-2608-9 |